SQIM co-designs with nature to develop cutting edge technologies and deliver naturally grown products with superior properties, employing fungal mycelium as its engineering and manufacturing platform, and serving its two verticals - EPHEA and MOGU. By matching mycelium based biofabrication processes with Deep Tech & Data-driven Approaches, SQIM’s mycofoundry sets the grounds to design a new material world that is responsibly rooted in generative processes, as it is driven by the desire to literally engage with life and for life.
| Website | https://www.sqim.bio/ |
| Employees | 18 (9 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Fungal Biotechnology, Mycelium Products, Sustainable Biomaterials, Bio-Based Products, Sustainable Materials, Innovative Materials, Cutting-Edge Materials, Renewable Materials, Natural Materials, Green Technology, Plant-Based Materials, Eco-Friendly Materials, Biotechnology |
| Competitors | Nimbus Therapeutics, Maven Bio, Rgenix, Evaxion Biotech, Fate Therapeutics Inc, Octant, AbCellera, Zymergen, Inc., Geno, CureVac +36 more (view full list) |
Looking for a particular SQIM employee's phone or email?
Stefano Babbini is the CEO and Co-Founder of SQIM.
9 people are employed at SQIM.